Format

Send to

Choose Destination
Neuropsychopharmacology. 2019 Jul 14. doi: 10.1038/s41386-019-0463-z. [Epub ahead of print]

Sleep and neurological autoimmune diseases.

Author information

1
Neurology Service, Sleep Center, Hospital Clinic de Barcelona, Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain. airanzo@clinic.cat.

Abstract

Neurological autoimmune diseases are characterized by an inappropriate immune response that by mistake targets the nervous system. As a result, patients experiment a number of neurological manifestations that may include insomnia, excessive daytime sleepiness, cataplexy, central hypoventilation, and REM sleep behavior disorder. Polysomnographic evaluation may reveal disorganized sleep architecture involving both NREM and REM sleep, and REM sleep intrusions into wakefulness. The study of sleep disorders in the setting of autoimmune diseases (e.g., narcolepsy, anti-IgLON5 disease, paraneoplastic neurological syndromes) shows that an abnormal immune-mediated (humoral or cellular) response target the neuronal structures (e.g., brainstem, hypothalamus) and neurotransmitters systems (e.g., hypocretin) that regulate sleep resulting in sleep impairment. It is a window to examine the link between the autoimmune system and the sleep regulation at the molecular, cellular, and anatomic level.

PMID:
31302665
DOI:
10.1038/s41386-019-0463-z

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center